Mayo Clinic Cancer Center gives inaugural Inclusion of Minorities in Clinical Trials awards

The Mayo Clinic Cancer Center announced awardees of its inaugural Inclusion of Minorities in Clinical Trials award to enhance recruitment into interventional clinical trials that address a cancer health disparity impacting black/African American, Native American or Hispanic populations.

Award recipients and their projects

Matthew Goetz, M.D. (HEMO ’03)
Division of Medical Oncology, Department of Oncology
Professor of oncology and pharmacology 
Mayo Clinic in Rochester
“Therapeutic Targeting of ER Beta in Triple Negative Breast Cancer"
Will expand a phase II clinical trial to determine the therapeutic efficacy of estradiol in patients with ERβ- positive triple negative breast cancer to Mayo Clinic in Florida with the aim of enrolling more African Americans. Preliminary evidence indicates that ERβ appears to be present at a similar frequency in African Americans as it is in Caucasians (20%). For this reason it is critical to test whether ERβ can be targeted with estradiol in both Caucasian and African American women.

Donald Northfelt, M.D. (HEMO ’02)
Division of Hematology and Medical Oncology, Department of Internal Medicine
Professor of medicine
Mayo Clinic in Arizona
Bhavika Patel, M.D. (RD ’15)
Division of Breast Imaging, Department of Radiology
Assistant professor of radiology 
Mayo Clinic in Arizona
“Enhancing Diversity in Cancer Clinical Trials through Community Engagement: Tomosynthesis Mammographic Imaging Screening Trial at MCA”
Aims to determine whether screening for breast cancer with tomosynthesis mammography is superior to digital mammography; determine whether women who are screened for breast cancer with tomosynthesis mammography have fewer advanced breast cancers compared with the number of such cancers found when women are screened for breast cancer with digital mammography; increase minority patient numbers at Mayo Clinic in Arizona to mirror diversity of patients in the Cancer Center’s catchment area by targeting outreached to community clinical partner sites; leverage unique community assets and resources to promote cancer prevention initiatives to lessen the burden of cancers of particular concern in the Cancer Center’s catchment area. 

Niloy Jewel Samadder, M.D. (GIAE ’11)
Division of Gastroenterology and Hepatology, Department of Internal Medicine
Associate professor of medicine 
Mayo Clinic in Arizona
“A Trial of Proactive Genetic Testing in Under-represented Populations with Cancer”
Will evaluate the integration of cancer genetic testing into a cancer clinical practice aimed at patients of various ethnic populations in Arizona — including but not limited to Hispanic/Latino, Native American/Alaskan, African American, and Asian. If successful this project will provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations. 

 

Recommended reading

Posts about similar topics: